MAIA Biotechnology, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
MAIA on NYSE
Industry
Pharmaceutical Preparations
Location
444 West Lake Street, Suite 1700, Chicago, IL

Insiders trading volume in the past year

MAIA Biotechnology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stan Smith Director $2.65M +$1.53M +137% Nov 1, 2024
Louie Ngar Yee Director $2.44M +$507K +26.2% Oct 1, 2024
Ramiro Guerrero Director $1.24M +$439K +54.7% Nov 1, 2024
Cristian Luput Director $1.05M +$277K +36% Nov 1, 2024
Steven M. Chaouki Director $347K +$191K +123% Nov 1, 2024
Vlad Vitoc Chief Executive Officer, Director, 10%+ Owner $103K Nov 5, 2024
Jean-Manasse Theagene Director $18.1K Oct 1, 2024
Jeffrey Himmelreich Head of Finance Apr 30, 2024
Joseph Mcguire Chief Financial Officer May 31, 2023
Laurentiu Vlad Director Dec 30, 2022
Mihail Obrocea Chief Medical Officer May 31, 2023
Sergei Gryaznov Chief Scientific Officer Apr 30, 2024

Recent Insider Transactions by Companies or Individuals for MAIA Biotechnology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.